Literature DB >> 17331657

Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala.

A J McDonald1, F Mascagni.   

Abstract

Although it is well established that there are alterations in type 2A 5-HT receptors (5-HT2ARs) in the basolateral nuclear complex of the amygdala (BLC) in several neuropsychiatric disorders, very little is known about the neuronal localization of these receptors in this brain region. Single-labeling and dual-labeling immunohistochemical techniques were utilized in the rat to address this question. Three different 5-HT2AR antibodies were used, each producing distinct but overlapping patterns of immunostaining. Two of three 5-HT2AR antibodies mainly stained pyramidal projection neurons in the BLC. The third antibody only stained pyramidal cells in the dorsolateral subdivision of the lateral amygdalar nucleus. With one of the antibodies, the most intensely stained neurons were a population of large nonpyramidal neurons whose morphology and distribution closely resembled those shown in previous studies to project to the mediodorsal thalamic nucleus (MD). This was confirmed in the present study using a technique that combined 5-HT2AR immunohistochemistry with fluorogold retrograde tract-tracing. Two of three 5-HT2AR antibodies stained large numbers of parvalbumin-containing interneurons in the BLC. One of these two antibodies also stained a subpopulation of somatostatin-containing neurons. None of the 5-HT2AR antibodies stained significant numbers of the other two main interneuronal subpopulations, the large cholecystokinin-positive neurons or the small interneurons that exhibit extensive colocalization of calretinin and cholecystokinin. Since each of the three antibodies was raised against a distinct immunizing antigen, they may recognize different conformations of 5-HT2AR in different neuronal domains. The expression of 5-HT2ARs in pyramidal cells and parvalbumin-positive interneurons in the BLC is consistent with the results of previous electrophysiological studies, and suggests that 5-HT may produce excitation of several neuronal populations in the BLC via 5-HT2ARs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331657      PMCID: PMC1941573          DOI: 10.1016/j.neuroscience.2007.01.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  66 in total

1.  Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system.

Authors:  M-C Miquel; M B Emerit; A Nosjean; A Simon; P Rumajogee; M-J Brisorgueil; E Doucet; M Hamon; D Vergé
Journal:  Eur J Neurosci       Date:  2002-02       Impact factor: 3.386

2.  5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala.

Authors:  C Stein; H Davidowa; D Albrecht
Journal:  Synapse       Date:  2000-12-01       Impact factor: 2.562

3.  A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala.

Authors:  F Mascagni; A J McDonald
Journal:  Neuroscience       Date:  2006-12-05       Impact factor: 3.590

4.  Production and characterization of a specific 5-HT2 receptor antibody.

Authors:  S J Garlow; D A Morilak; R R Dean; B L Roth; R D Ciaranello
Journal:  Brain Res       Date:  1993-06-25       Impact factor: 3.252

5.  Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain.

Authors:  T Xu; S C Pandey
Journal:  Brain Res Bull       Date:  2000-04       Impact factor: 4.077

6.  Parvalbumin-containing neurons in the rat basolateral amygdala: morphology and co-localization of Calbindin-D(28k).

Authors:  A J McDonald; R L Betette
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

7.  Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord.

Authors:  M Morales; E Battenberg; F E Bloom
Journal:  J Comp Neurol       Date:  1998-12-21       Impact factor: 3.215

8.  Serotonin type II receptor activation facilitates synaptic plasticity via N-methyl-D-aspartate-mediated mechanism in the rat basolateral amygdala.

Authors:  A Chen; C J Hough; H Li
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.

Authors:  B L Roth; E P Palvimaki; S Berry; N Khan; N Sachs; A Uluer; M S Choudhary
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

10.  Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology.

Authors:  F Condé; J S Lund; D M Jacobowitz; K G Baimbridge; D A Lewis
Journal:  J Comp Neurol       Date:  1994-03-01       Impact factor: 3.215

View more
  46 in total

1.  Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling.

Authors:  Patrick M Fisher; Carolyn C Meltzer; Julie C Price; Rhaven L Coleman; Scott K Ziolko; Carl Becker; Eydie L Moses-Kolko; Sarah L Berga; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2009-03-25       Impact factor: 5.357

2.  Serotonergic control of GABAergic inhibition in the lateral amygdala.

Authors:  Ryo Yamamoto; Takafumi Furuyama; Tokio Sugai; Munenori Ono; Denis Pare; Nobuo Kato
Journal:  J Neurophysiol       Date:  2019-12-25       Impact factor: 2.714

3.  Effects of dominance status on conditioned defeat and expression of 5-HT1A and 5-HT2A receptors.

Authors:  Kathleen E Morrison; Cody L Swallows; Matthew A Cooper
Journal:  Physiol Behav       Date:  2011-02-26

4.  GABAergic somatostatin-immunoreactive neurons in the amygdala project to the entorhinal cortex.

Authors:  A J McDonald; V Zaric
Journal:  Neuroscience       Date:  2015-01-28       Impact factor: 3.590

5.  Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; Dave Arendt; Gerald A Deehan; Lauren M Federici; Cristian Bernabe; Eric A Engleman; Zachary A Rodd; Christopher A Lowry; Anantha Shekhar
Journal:  Pharmacol Biochem Behav       Date:  2015-11       Impact factor: 3.533

Review 6.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

7.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

Review 8.  Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.

Authors:  Esther Asan; Maria Steinke; Klaus-Peter Lesch
Journal:  Histochem Cell Biol       Date:  2013-03-15       Impact factor: 4.304

Review 9.  Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions.

Authors:  Cristiano Bombardi; Giuseppe Di Giovanni
Journal:  Exp Brain Res       Date:  2013-04-17       Impact factor: 1.972

Review 10.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.